| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | €442.4M | −4.5% |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | -€25.0M | — |
| Diluted EPS | -€1.77 | — |
| Free Cash Flow | €215.7M | +47.1% |
| DPS (FY2025) | €0.60 |
| Trailing yield | — |
| Payout ratio | — |
| Growth streak | 0 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | €0.60 | — | reported |
| Ratio | 2024 | 2025 | Trend · 2y | vs own |
|---|---|---|---|---|
| ▾Margins | ||||
| Net Margin | −0.65% | −5.66% | 25% | |
| FCF Margin | 31.66% | 48.75% | 75% | |
| OCF Margin | 32.42% | 49.02% | 75% | |
| Capex Intensity | 0.76% | 0.28% | 25% | |
| ▸Returns on Capital · 2 ratios | ||||
| ▸DuPont factors (ROE drivers) · 3 ratios | ||||
| ▸Earnings quality · 2 ratios | ||||
| ▸Leverage · 2 ratios | ||||
| ▸Capital allocation · 4 ratios | ||||
| Line | 2024 | 2025 |
|---|---|---|
| Revenue | €463.1M | €442.4M |
| YoY % | -4.5% | |
| SG&A Expense | €121.8M | €110.2M |
| YoY % | -9.5% | |
| Total Operating Expenses | €451.2M | €374.2M |
| YoY % | -17.1% | |
| Pretax Income | €206,000 | -€3.3M |
| Income Tax | €3.2M | €21.7M |
| YoY % | +578.2% | |
| Net Income (incl. NCI) | -€3.0M | -€25.0M |
| Net Income | -€3.0M | -€25.0M |
| EPS (Basic) | -€0.21 | -€1.77 |
| EPS (Diluted) | -€0.21 | -€1.77 |
| Weighted Avg Shares (Basic) | 14.2M | 14.2M |
| YoY % | -0.1% | |
| Dividends Declared per Share | €1 | €1 |
| YoY % | -52.8% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
